PMID: 2501445Jul 1, 1989Paper

Exacerbation of murine listeriosis by a monoclonal antibody specific for the type 3 complement receptor of myelomonocytic cells. Absence of monocytes at infective foci allows Listeria to multiply in nonphagocytic cells

The Journal of Experimental Medicine
H RosenR J North

Abstract

Treatment of mice with a rat mAb (5C6) specific for an epitope of the type 3 complement receptor of myelomonocytic cells severely interfered with the ability of the mice to resist infection with Listeria monocytogenes. Consequently, a sublethal infection was rapidly converted to a lethal one that resulted in death in 5 d. However, infection was only exacerbated if 5C6 was given earlier in infection, before mononuclear phagocytes populated sites of Listeria implantation in the liver and spleen. If given after day 3 of infection, 5C6 caused only a temporary increase in bacterial multiplication. The infection-enhancing effect of 5C6 was associated with failure of mice to focus mononuclear phagocytes at sites of bacterial multiplication of Listeria in liver hepatocytes and extracellulary in the spleen. This resulted in unrestricted multiplication of Listeria in hepatocytes and extracellularly in the spleen. The results are in keeping with the ability of 5C6 to inhibit the accumulation of myelomonocytic cells in peritoneal inflammatory exudates, as revealed by a previous study.

Citations

Aug 28, 1990·Journal of Immunological Methods·P L GoossensG Milon
Dec 1, 1990·FEMS Microbiology Immunology·A S Cross, N M Kelly
Oct 1, 1989·Current Opinion in Immunology·S H Kaufmann, M J Reddehase
Aug 1, 1991·Current Opinion in Immunology·G E Grau, R L Modlin
Feb 1, 1992·Current Opinion in Immunology·D A Portnoy
May 26, 1999·Infectious Disease Clinics of North America·C Parent, P Q Eichacker
Jul 13, 2000·FEMS Immunology and Medical Microbiology·T MiuraA Nakane
Oct 2, 2004·Nature Reviews. Immunology·Eric G Pamer
Dec 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·J T HartyM J Bevan
Dec 1, 1989·The Journal of Experimental Medicine·D A PortnoyL G Tilney
Dec 1, 1991·The Journal of Experimental Medicine·H HockT Blankenstein
Feb 1, 1996·The Journal of Experimental Medicine·J L GaillardP Berche
Jan 6, 2000·The Journal of Experimental Medicine·C A ThomasJ El Khoury
Nov 1, 1996·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·R HärtlG J del Zoppo
Apr 1, 1993·Molecular Microbiology·A CamilliD A Portnoy
Feb 1, 1993·Alcoholism, Clinical and Experimental Research·A J SaadT R Jerrells
Mar 1, 1992·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·M A Jutila
Jul 4, 2001·Clinical Microbiology Reviews·J A Vázquez-BolandJ Kreft
Feb 14, 2013·Infection and Immunity·Nelly LeungKeith Ireton
Sep 23, 2003·Infection and Immunity·Huaizhu WuChristie M Ballantyne
Jun 24, 2003·Infection and Immunity·Emma ErikssonMartin E Rottenberg
Feb 29, 2008·Annual Review of Immunology·Natalya V SerbinaEric G Pamer
Feb 1, 1993·The American Review of Respiratory Disease·P F PiguetG E Grau
Jul 1, 1990·American Journal of Respiratory Cell and Molecular Biology·H Rosen, S Gordon
Aug 4, 1999·Proceedings of the National Academy of Sciences of the United States of America·A F OchsenbeinR M Zinkernagel

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.